Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Biopharmaceutical
Sinobiomed Announces New Chief Executive Officer
September 02, 2010
New, Experienced Management Intends to Move Swiftly on Funding, Acquisitions and Corporate Initiatives
Biodel Announces Name Change for Lead Product Candidate
September 01, 2010
Currently under review by the U.S. Food and Drug Administration
XenoPort Announces Changes to Executive Team
August 26, 2010
William J. Rieflin to resign as President
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
August 26, 2010
New Indication Seeks to Help Protect Infants and Toddlers Against Meningococcal Disease
Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension
August 25, 2010
Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010
Nabi Biopharmaceuticals Significantly Enhances NicVAX Patent Portfolio
August 24, 2010
Patent Issued for Exclusive Use of NicVAX and Related Nicotine Vaccines to Treat or Prevent Nicotine Addiction
Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer
August 24, 2010
Supplements Special Protocol Assessment for Global Phase III HEAT Study
Additional Phase III clinical trial with Urocidin(TM) expected to commence in 2010
August 19, 2010
Analysis of data from first Phase III clinical trial nearing completion
Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
August 17, 2010
Mr. Stewart has more than 30 years of experience in executive management and commercial positions
Pacific Biosciences Expands Into European Union
August 03, 2010
Terry Pizzie Appointed Vice President, Europe
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
July 30, 2010
Former Idun Management team to expand efforts in liver disease and oncology
Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA®
July 23, 2010
Results Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
Prochymal New Drug Submission Granted Priority Review by Health Canada
July 21, 2010
Health Canada to add first-in-class stem cell therapy to Register of Innovative Drugs providing eight years of market exclusivity
FDA Accepts AFREZZA Complete Response Resubmission
July 20, 2010
FDA Sets Target Action Date of December 29, 2010
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
July 14, 2010
Dr. Brennan has over 10 years experience in business development
Kamada Wins FDA Approval for GlassiaTM
July 06, 2010
A New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficie
Actelion Introduces First Pulmonary Arterial Hypertension (PAH) Multimedia Mobile Application for Healthcare Professionals
June 10, 2010
Application provides on-the-go disease pathology, diagnosis, treatment information
Alnylam Strengthens Management Team with New Key Appointments
June 02, 2010
Appoints Laurence Reid, Ph.D. as SVP, Chief Business Officer
Rigel Pharmaceuticals Names Raul Rodriguez President
June 01, 2010
Ryan Maynard and Dolly Vance Promoted to Executive Vice Presidents
Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing
May 26, 2010
FDA's completed review for DUEXA is expected in the first quarter of 2011
3-V Biosciences Expands Leadership Team
May 13, 2010
Opens New Facility and Integrates Operations
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
May 06, 2010
Dr. Pitler brings to Chimerix more than 25 years of experience
Dicerna Names Douglas Fambrough as Chief Executive Officer
May 06, 2010
Appointment Strategically Positions Company for Next Phase of Growth
AVI BioPharma Appoints David Boyle Interim President and CEO
April 21, 2010
Anthony Chase, Joins AVI Board
Positive Phase III Diabetes Data with Lixisenatide Announced by Zealand Pharma's Partner sanofi-aventis
April 15, 2010
Once daily Lixisenatide meets Phase III Study Endpoints in Diabetes
VaxGen to Acquire diaDexus in a Stock-for-Stock Merger
April 14, 2010
diaDexus will use cash to fund continued adoption of the PLAC(R) Test
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
April 09, 2010
Acquisition Diversifies Global Pharmaceutical Business
Cephalon Completes Acquisition of Ception Therapeutics
April 05, 2010
Acquisition Adds Biologics Asset for Advancement to Phase Three Development
Horizon Therapeutics and Nitec Pharma Complete Merger and Combine Businesses
April 01, 2010
Combined company has one approved product and two late-stage candidates
Santarus Announces Launch of ZEGERID OTC by Schering-Plough Consumer HealthCare
April 01, 2010
ZEGERID OTC Now Available on Retail Store Shelves in the U.S.
Latest News
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Most Popular
Most Emailed
Most Recent
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Novartis receives FDA approval of Tekamlo
Meda acquires Alaven, a US specialty pharma company
XenoPort Announces Changes to Executive Team
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Pfizer to Acquire FoldRx Pharmaceuticals
Medicis Announces Approval of Additional Strengths of Solodyn(R)
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Meda acquires Alaven, a US specialty pharma company
Novo Nordisk Creates 'App' to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
Biodel Announces Name Change for Lead Product Candidate
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Medicis Announces Approval of Additional Strengths of Solodyn(R)
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Pfizer to Acquire FoldRx Pharmaceuticals
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Diagnostic
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Regulatory Approval
Research & Development